It is upregulated in many tumours (where its expression level correlates with poor prognosis) and decreasing METTL9 expression in hepatocellular carcinoma cells slows down their proliferation and ability to generate tumours in vivo as well as their invasiveness17. Here, METTL9 is linked to neoplasm.